Pancreas Transplant Recovery: Post-Operative Monitoring and Long-Term Care

Pancreas transplantation (often simultaneous pancreas-kidney for type 1 diabetes) is a major surgery requiring intensive monitoring.

Early Post-Op Risks (Hospital Phase)

• Rejection: Cell-mediated (acute) or antibody-mediated. Monitored via blood glucose, amylase/lipase, biopsy if indicated.
• Infection: Surgical site, urinary tract, CMV, opportunistic. Prophylactic antimicrobials used.
• Thrombosis: Graft thrombosis (major cause of early loss). Anticoagulation protocol.
• Pancreatitis: Ischemia-reperfusion injury → elevated amylase/lipase.
• Bleeding: Surgical or coagulopathy-related.
• Hyperglycemia/Diabetes: If graft function suboptimal.

Monitoring in Hospital

• Frequent blood glucose (hourly initially)
• Daily CBC, chemistries, amylase/lipase, tacrolimus/sirolimus levels
• Imaging (US with Doppler) for vascular patency
• Biopsy for suspected rejection

Long-Term Follow-Up

• Lifelong immunosuppression (tacrolimus, MMF, prednisone)
• Regular labs: glucose, HbA1c, renal function, drug levels
• Surveillance for malignancy (skin, PTLD), cardiovascular disease, bone health
• Annual graft biopsy in some protocols

Multidisciplinary team (transplant surgeon, endocrinologist, nephrologist, coordinator) optimizes outcomes. 1-year graft survival >85% (SPK).